Bosch, Elisabeth
Güse, Esther
Kirchner, Philipp
Winterpacht, Andreas
Walther, Mona
Alders, Marielle
Kerkhof, Jennifer
Ekici, Arif B.
Sticht, Heinrich
Sadikovic, Bekim
Reis, André
Vasileiou, Georgia
Funding for this research was provided by:
Universitätsklinikum Erlangen
Article History
Received: 2 April 2024
Accepted: 7 July 2024
First Online: 19 July 2024
Declarations
:
: Legal guardians gave written informed consent for genetic and clinical data, including photos, to be published. This study follows the Declaration of Helsinki protocols and is approved by the ethical committee of the Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany (259_16 Bc).
: Bekim Sadikovic is a shareholder in EpiSign Inc, a company involved in commercialization of EpiSign technology. The remaining authors declare no competing interests.